ZHIJIAN XUE – Trademark Portfolio

Entity Type: 98

ZHIJIAN XUE holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 2 filings in this category. The portfolio also extends into Class 18 (Leather Goods) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include 1HORA and MOLANU.

FLORENCIA NUM. EXT. 31,

NUM. INT. 301-304, JUÁREZ, CUAUHTÉMOC 06600 DISTRITO FEDERAL

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

1H
1H
Abandoned 2023
MOLANU
MOLANU
Registered 2021
1HORA
1HORA
Registered 2020

Trademark Classifications

ZHIJIAN XUE's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (2 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

18
Leather Goods (1 filing)

Leather and imitations of leather; animal skins, hides; trunks and travelling bags

Frequently Asked Questions

How many trademarks does ZHIJIAN XUE have?

ZHIJIAN XUE has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned.

What trademark classes does ZHIJIAN XUE file in?

ZHIJIAN XUE files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 18 (Leather Goods). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are ZHIJIAN XUE's most well-known trademarks?

ZHIJIAN XUE's registered trademark portfolio includes well-known marks such as 1HORA and MOLANU. These are among 2 currently registered trademarks in the portfolio.

What is ZHIJIAN XUE's trademark registration success rate?

ZHIJIAN XUE has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.